Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation.
Rasmus RiviniusMatthias HelmschrottAnn-Kathrin RahmFabrice F DarcheDierk ThomasTom BrucknerAndreas O DoeschHugo A KatusPhilipp EhlermannPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2020)
Patients receiving ivabradine showed a superior heart rate reduction and a better left ventricular diastolic function along with an improved 5-year survival after HTX.
Keyphrases
- heart rate
- blood pressure
- heart rate variability
- left ventricular
- ejection fraction
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- heart failure
- aortic stenosis
- peritoneal dialysis
- prognostic factors
- acute myocardial infarction
- cardiac resynchronization therapy
- atrial fibrillation
- acute coronary syndrome